Development of paclitaxel-loaded liposomal systems with anti-her2 antibody for targeted therapy

Creative Commons License

BÜYÜKKÖROĞLU G., ŞENEL B., BAŞARAN E., Gezgin S.

TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, cilt.15, sa.5, ss.895-903, 2016 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 15 Sayı: 5
  • Basım Tarihi: 2016
  • Doi Numarası: 10.4314/tjpr.v15i5.1
  • Dergi Adı: TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.895-903
  • Anahtar Kelimeler: Cancer, Anti-her2 antibody, Liposome, Paclitaxel, Targeted therapy, Cell culture, SOLID LIPID NANOPARTICLES, MONOCLONAL-ANTIBODY, DELIVERY, CANCER, PLUS
  • Anadolu Üniversitesi Adresli: Evet

Özet

Purpose: To develop liposome formulations containing monoclonal antibody anti-HER2 (MabHer2), and Paclitaxel (PTX).